Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Lycera (United States) | Researchclopedia

Back to institutions

Lycera (United States)

Ann Arbor, Michigancompany

51

Works

10,235

Citations

67

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Immune Cell Function and Interaction

Top Researchers

Xiao Hu Florida State University

9,318 works207,417 citationsh-index: 178

Recent Research

Discovery of HC-7366: An Orally Bioavailable and Efficacious GCN2 Kinase Activator

Christopher G. Thomson,Thomas D. Aicher,et al.

202414 citations

Cytokine Signaling Pathways and Interactions

T-cell and B-cell Immunology

Psoriasis: Treatment and Pathogenesis

Inflammasome and immune disorders

Immune cells in cancer

Inflammatory Bowel Disease

CAR-T cell therapy research

Mitochondrial Function and Pathology

Mycobacterium research and diagnosis

Daniel E. Furst University of Southern California

567 works49,439 citationsh-index: 98

Donald P. Tashkin University of California, Los Angeles

771 works38,961 citationsh-index: 107

Maureen D. Mayes The University of Texas Health Science Center

485 works38,359 citationsh-index: 92

Costas A. Lyssiotis University of Michigan

756 works32,463 citationsh-index: 79

James L.M. Ferrara

450 works29,411 citationsh-index: 91

Discovery of LYC-55716: A Potent, Selective, and Orally Bioavailable Retinoic Acid Receptor-Related Orphan Receptor-γ (RORγ) Agonist for Use in Treating Cancer

Thomas D. Aicher,Chad A. Van Huis,et al.

202124 citations

Fully automated endoscopic disease activity assessment in ulcerative colitis

Heming Yao,Kayvan Najarian,et al.

2020113 citations

P595 Feasibility and performance of a fully automated endoscopic disease severity grading tool for ulcerative colitis using unaltered multisite videos

Ryan W. Stidham,Heming Yao,et al.

20202 citations

Phase 1 Open-Label, Multicenter Study of First-in-Class RORγ Agonist LYC-55716 (Cintirorgon): Safety, Tolerability, and Preliminary Evidence of Antitumor Activity

Devalingam Mahalingam,Judy S. Wang,et al.

201972 citations

Novel small-molecule RORγ agonist immuno-oncology agent LYC-55716: Safety and efficacy in a phase IIA open-label, multicenter trial

J. Wang,Stephen V. Liu,et al.

20180 citations